CNS PHARMACEUTICALS INC. - 1H - Technical analysis published on 04/06/2023 (GMT)
- 124
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Additional analysis
Quotes
The CNS PHARMACEUTICALS INC. rating is 1.200 USD. The price registered an increase of +38.57% on the session and was between 1.160 USD and 1.410 USD. This implies that the price is at +3.45% from its lowest and at -14.89% from its highest.The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by CNS PHARMACEUTICALS INC.:
New LOW record (5 years)
Type : Bearish
Timeframe : Weekly
New LOW record (1 year)
Type : Bearish
Timeframe : Weekly
New LOW record (1st january)
Type : Bearish
Timeframe : Weekly
New LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Abnormal volumes on CNS PHARMACEUTICALS INC. were detected by the Central Volumes scanner:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of this 1H chart of CNS PHARMACEUTICALS INC. indicates that the overall trend is bearish. 64.29% of the signals given by moving averages are bearish. Caution: the slightly bullish signals currently given by short-term moving averages show a possible weakening of the global trend. The Central Indicators scanner detects a bearish signal on moving averages that could impact this trend:
Moving Average bearish crossovers : AMA50 & AMA100
Type : Bearish
Timeframe : 1 hour
An assessment of technical indicators does not currently provide any relevant information to suggest whether the signal given by the technical indicators is more bullish or bearish.
But beware of excesses. The Central Indicators scanner currently detects this:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : 1 hour
Pivot points : price is under support 1
Type : Neutral
Timeframe : 1 hour
Pivot points : price is under support 1
Type : Neutral
Timeframe : Weekly
Momentum indicator is back under 0
Type : Bearish
Timeframe : 1 hour
No signals are given by Central Patterns, a market scanner specialised in chart patterns, resistances and supports.
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|
ProTrendLines | 1.182 | 1.200 | 1.390 | 1.603 | 2.100 |
Change (%) | -1.50% | - | +15.83% | +33.58% | +75.00% |
Change | -0.018 | - | +0.190 | +0.403 | +0.900 |
Level | Major | - | Minor | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.795 | 0.831 | 0.848 | 0.884 | 0.901 | 0.937 | 0.954 |
Camarilla | 0.851 | 0.856 | 0.861 | 0.866 | 0.871 | 0.876 | 0.881 |
Woodie | 0.787 | 0.826 | 0.840 | 0.879 | 0.893 | 0.932 | 0.946 |
Fibonacci | 0.831 | 0.851 | 0.863 | 0.884 | 0.904 | 0.916 | 0.937 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.643 | 0.787 | 0.893 | 1.037 | 1.143 | 1.287 | 1.393 |
Camarilla | 0.931 | 0.954 | 0.977 | 1.000 | 1.023 | 1.046 | 1.069 |
Woodie | 0.625 | 0.778 | 0.875 | 1.028 | 1.125 | 1.278 | 1.375 |
Fibonacci | 0.787 | 0.882 | 0.941 | 1.037 | 1.132 | 1.191 | 1.287 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | -0.333 | 0.299 | 0.649 | 1.281 | 1.631 | 2.263 | 2.613 |
Camarilla | 0.730 | 0.820 | 0.910 | 1.000 | 1.090 | 1.180 | 1.270 |
Woodie | -0.473 | 0.229 | 0.509 | 1.211 | 1.491 | 2.193 | 2.473 |
Fibonacci | 0.299 | 0.674 | 0.906 | 1.281 | 1.656 | 1.888 | 2.263 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 38.36 | |
MACD (12,26,9): | -0.0300 | |
Directional Movement: | -17.740 | |
AROON (14): | -100.000 | |
DEMA (21): | 0.890 | |
Parabolic SAR (0,02-0,02-0,2): | 0.941 | |
Elder Ray (13): | -0.023 | |
Super Trend (3,10): | 1.002 | |
Zig ZAG (10): | 0.866 | |
VORTEX (21): | 0.7730 | |
Stochastique (14,3,5): | 6.39 | |
TEMA (21): | 0.882 | |
Williams %R (14): | -100.00 | |
Chande Momentum Oscillator (20): | -0.080 | |
Repulse (5,40,3): | -9.1800 | |
ROCnROLL: | 2 | |
TRIX (15,9): | -0.3740 | |
Courbe Coppock: | 12.66 |
MA7: | 0.962 | |
MA20: | 1.102 | |
MA50: | 1.598 | |
MA100: | 2.490 | |
MAexp7: | 0.896 | |
MAexp20: | 0.929 | |
MAexp50: | 0.981 | |
MAexp100: | 1.070 | |
Price / MA7: | +24.74% | |
Price / MA20: | +8.89% | |
Price / MA50: | -24.91% | |
Price / MA100: | -51.81% | |
Price / MAexp7: | +33.93% | |
Price / MAexp20: | +29.17% | |
Price / MAexp50: | +22.32% | |
Price / MAexp100: | +12.15% |
News
The last news published on CNS PHARMACEUTICALS INC. at the time of the generation of this analysis was as follows:
- CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM
- CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme
- CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
- CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
- CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin
Add a comment
Comments
0 comments on the analysis CNS PHARMACEUTICALS INC. - 1H